Genesys International Corp Complete Financial Statements

11 Years of Data
2025 - 2015

In FY2025, Genesys International Corp (GENESYS) reported revenue ₹81 Cr, net profit ₹12 Cr and EPS ₹2.89, with a net profit margin of 14.8% and ROE of 2.2%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Genesys International Corp stock price NSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 14.81% 2025 data
EBITDA Margin 41.98% 2025 data
Operating Margin 39.00% 2025 data
Return on Assets 1.54% 2025 data
Return on Equity 2.15% 2025 data

Balance Sheet Ratios

Current Ratio 14.22 2025 data
Equity Ratio 71.59% 2025 data
Asset Turnover 0.10 2025 data

GENESYS Revenue, Net Profit & EBITDA — Year-on-Year Growth

GENESYS YoY (Sept 2024 vs Sept 2025) — revenue +11.0%, net profit +9.1%, EBITDA +13.3%, expenses +9.3%. Explore Genesys International Corp intrinsic price to estimate fundamental worth using multiple valuation models.

Revenue Growth
+11.0%
Year-over-Year
Net Profit Growth
+9.1%
Year-over-Year
EBITDA Growth
+13.3%
Year-over-Year
Expense Growth
+9.3%
Year-over-Year
Assets Growth
+22.5%
Year-over-Year
Equity Growth
+13.4%
Year-over-Year
Operating Cash Flow Growth
-378.9%
Year-over-Year
Investing Cash Flow Growth
+77.5%
Year-over-Year
Financing Cash Flow Growth
-28.2%
Year-over-Year

GENESYS Income Statement — Revenue, EBITDA & Net Profit

Genesys International Corp revenue ₹81 Cr, EBITDA ₹34 Cr, net profit ₹12 Cr, EPS ₹2.89 (2025) — net profit margin 14.8%. Review GENESYS price earnings ratio to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Jun 2016 Dec 2016
Revenue 81 94 72 87 73 72 57 91 34 48 36 62 39 37 44 56 32 32 14 40 22 21 4 23 29 41 37 29 23 26 24 30 30 5 30 32 22 19 22
Expenses 47 44 41 65 43 35 35 47 26 30 29 29 26 71 31 35 23 55 18 25 14 24 28 17 23 34 27 25 21 19 18 24 19 6 19 21 13 13 13
EBITDA 34 50 31 22 30 37 22 44 9 18 7 33 13 -34 13 21 9 -23 -4 14 8 -3 -24 7 6 7 10 4 2 7 6 7 11 -1 11 10 9 6 9
Operating Profit Margin % 39.00% 53.00% 42.00% 14.00% 41.00% 51.00% 37.00% 48.00% 23.00% 35.00% 17.00% 52.00% 29.00% -100.00% 27.00% 36.00% 27.00% -75.00% -34.00% 36.00% 36.00% -27.00% -673.00% 28.00% 18.00% 17.00% 27.00% 12.00% 2.00% 28.00% 21.00% 23.00% 34.00% -29.00% 34.00% 30.00% 37.00% 30.00% 38.00%
Depreciation 16 15 15 17 12 11 12 16 11 11 11 11 9 5 8 9 5 5 5 5 5 5 5 5 5 4 5 5 4 2 4 6 4 4 4 3 2 2 2
Interest 3 3 3 3 2 1 1 3 1 1 1 1 1 0 1 0 1 2 1 1 1 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 1 1 1
Profit Before Tax 15 32 12 2 16 24 9 26 -3 6 -5 21 3 -39 4 12 4 -30 -9 9 3 -9 -29 1 0 2 4 -2 -3 4 2 0 6 -5 6 7 6 4 7
Tax 3 13 5 1 5 9 4 5 1 4 0 5 0 2 3 4 0 -3 -1 2 0 0 0 0 -1 3 1 -1 1 0 1 0 2 -4 2 0 -1 1 3
Net Profit 12 19 7 1 11 15 5 21 -3 2 -6 16 3 -41 2 8 4 -27 -9 6 3 -9 -29 2 1 -1 4 -1 -4 4 1 0 5 -2 4 6 7 3 4
Earnings Per Share (₹) 2.89 4.77 1.75 0.25 2.80 3.78 1.34 5.22 -0.49 0.63 -1.40 4.21 1.41 2.10 1.31 2.25 1.80 -8.66 -2.82 2.64 1.56 -2.81 -8.75 1.06 0.78 -0.22 1.74 -0.22 -0.23 1.41 0.84 0.97 2.42 -0.49 2.64 2.76 2.37 1.08 1.41

GENESYS Balance Sheet — Assets, Liabilities & Shareholders' Equity

GENESYS total assets ₹778 Cr, total equity ₹557 Cr, total liabilities ₹ Cr (2025) — ROE 2.2%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 778 635 506 319 304 365 383 385 324 262 244
Current Assets 455 331 243 128 75 120 133 128 94 72 95
Fixed Assets 128 156 158 138 194 203 208 217 179 22 21
Capital Work in Progress 156 113 65 19 0 0 0 0 0 0 0
Investments 0 0 51 6 8 15 11 11 25 0 7
Other Assets 495 366 232 156 102 147 165 157 120 240 217
LIABILITIES
Total Liabilities
Current Liabilities 32 35 29 10 12 15 6 6 6 6 5
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 557 491 408 236 255 306 316 319 264 210 208
Share Capital 20 20 19 16 16 16 16 16 15 15 15
Reserves & Surplus 536 469 368 170 158 197 208 209 152 195 176

GENESYS Cash Flow Statement — Operating, Investing & Financing

Genesys International Corp operating cash flow ₹-53 Cr, investing ₹-18 Cr, financing ₹51 Cr, net cash flow ₹-20 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -53 19 -35 28 19 31 -23 17 -3 45 1
Investing Activities -18 -80 -189 -20 -12 -15 -17 -38 13 -42 -4
Financing Activities 51 71 215 12 -8 -14 7 38 4 -2 3
Net Cash Flow -20 11 -9 20 -1 2 -34 17 14 1 0